AN2 Therapeutics Inc [NASDAQ: ANTX] traded at a low on Wednesday, posting a -6.78 loss after which it closed the day’ session at $1.10.
The results of the trading session contributed to over 125248 shares changing hands. Over the past one week, the price volatility of AN2 Therapeutics Inc stands at 7.22% while the volatility over the past one month is 4.60%.
The market cap for ANTX stock reached $33.20 million, with 30.14 million shares outstanding and 19.88 million shares in the current float. Compared to the average trading volume of 209.29K shares, ANTX reached a trading volume of 125248 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about AN2 Therapeutics Inc [ANTX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ANTX shares is $1.67 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ANTX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for AN2 Therapeutics Inc shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on August 09, 2024. The new note on the price target was released on August 09, 2024, representing the official price target for AN2 Therapeutics Inc stock. Previously, the target price had yet another raise to $5, while Leerink Partners analysts kept a Outperform rating on ANTX stock.
The Average True Range (ATR) for AN2 Therapeutics Inc is set at 0.07 The Price to Book ratio for the last quarter was 0.45, with the Price to Cash per share for the same quarter was set at 2.22.
How has ANTX stock performed recently?
AN2 Therapeutics Inc [ANTX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.51. With this latest performance, ANTX shares dropped by -7.56% in over the last four-week period, additionally sinking by -23.08% over the last 6 months – not to mention a drop of -49.31% in the past year of trading.
AN2 Therapeutics Inc [ANTX]: Deeper insight into the fundamentals
Return on Equity for this stock declined to -44.77%, with Return on Assets sitting at -44.77%.
Insider trade positions for AN2 Therapeutics Inc [ANTX]
The top three institutional holders of ANTX stocks are: RA CAPITAL MANAGEMENT, L.P. with ownership of 5.55 million shares, which is approximately 18.6131%. OCTAGON CAPITAL ADVISORS LP, holding 3.22 million shares of the stock with an approximate value of $$6.92 million in ANTX stocks shares; and OCTAGON CAPITAL ADVISORS LP, currently with $$4.49 million in ANTX stock with ownership which is approximately 7.0039%.
